Treating autoimmune and inflammatory diseases with enhanced regulatory T-cells

Treating autoimmune and inflammatory diseases with enhanced regulatory T-cells

Show other versions (1)

Interleukin-2 (IL-2) is the main cytokine supporting regulatory T-cells (Tregs) development, survival and suppressive activity. However, Tregs cannot produce IL-2 and fully depend on exogenous IL-2. Treg cell therapy products are grown for weeks in culture medium containing IL-2 concentration that a...

Full description

Saved in:
Bibliographic Details
Other Authors: Klatzmann, David (Speaker)
Format: Electronic Video
Language:English
Published: London : Henry Stewart Talks, 2022.
Series:Henry Stewart talks. Biomedical & life sciences collection.
Subjects:
Autoimmune diseases > Treatment.
Inflammation > Treatment.
Interleukin-2 > Therapeutic use.
T cells > Therapeutic use.
Adoptive Transfer.
Autoimmune Diseases > drug therapy.
Autoimmune Diseases > Immunology.
Cell- and Tissue-Based Therapy.
CTLA-4 Antigen.
Forkhead Transcription Factors.
Graft vs Host Disease > immunology.
Immunotherapy > methods.
Infections > immunology.
Interleukin-2 > therapeutic use.
Liver.
Lung.
Spleen.
T-Lymphocytes, Regulatory > therapeutic use.
Online Access:https://hstalks.com/bs/5115/
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://hstalks.com/bs/5115/

Similar Items